Vascular Response of Orsiro vs. Xience Drug-Eluting Stents for Treating Coronary Bifurcation Lesions

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

Also called NCT05200637

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05200637
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Taiwan (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05200637. Randomized; no masking; primary purpose treatment. Start 2022-02-01 (anticipated); primary completion 2024-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Vascular Response of Orsiro vs. Xience Drug-Eluting Stents for Treating Coronary Bifurcation Lesions
Intervention (Device)
Orsiro stent
Intervention (Device)
Xience stent
Intervention (Device)
Any drug-eluting stent
Lead sponsor
Chang Gung Memorial Hospital (class: other)

Record details

Record id
cardio:ct-nct05200637
Content hash
7e32be3d3ca0c21ed1573680fca0f3f1849966e97d5752ee207cc44160f18e1d